For release 7:00am 17 February 2026
Applied Nutrition plc
(the “Group”)
H1 FY26 Trading Update
Applied Nutrition plc, a leading sports nutrition, health and wellness brand, today announces an update on trading for the six months ended 31 January 2026 (“H1 FY26”).
H1 FY261 Trading Update
The Group delivered a very strong performance in the first half of the financial year, generating revenue of £74.5 million, an increase of 57% on H1 FY25 (£47.6 million). EBITDA for the period was also ahead of management expectations.
As noted in the December Trading Update, the Group entered the January peak Health, Fitness & Wellbeing period with retail orders and resultant customer stock levels, significantly above expectations. This is a consequence of the success of its channel diversification across UK high street health retailers, grocers and discounters. Together with accelerated demand for a number of H1 FY26 product launches, this is expected to result in a more H1‑weighted revenue profile than in prior years.
FY26 Outlook2
Reflecting the strong first‑half performance, the Group now anticipates that FY26 results will be ahead of updated market consensus expectations3. Management currently expects full‑year revenue of approximately £140 million.
Notice of Results
The Group will announce its Interim Results for the six months ended 31 January 2026 on 23 March 2026.
Analyst Presentation
Thomas Ryder, CEO, Steven Granite, COO and Joe Pollard, CFO, will host a virtual presentation and Q&A session for analysts at 09.00 GMT on 23 March 2026.
To register, please email appliednutrition@almastrategic.com
Retail Investor Presentation
Management will also host a virtual presentation and Q&A session for retail investors at 16.00 GMT on 23 March 2026.
To register to attend, please use the following link: https://engageinvestor.news/APN_IP_0326
Notes:
1 All figures used in this announcement relating to FY26 remain subject to audit.
2 Please see cautionary note regarding forward-looking statements below.
3 Consensus market expectations for FY26 as calculated by the Company immediately before this announcement are:
Measure
FY26
Revenue
£133.5 million
Adjusted EBITDA
£37.7 million
The Company periodically updates these calculations and publishes them at: https://www.appliednutritionplc.com/consensus-earnings-estimates
Further information and contacts
Information for investors can be found on the Group’s website at www.appliednutritionplc.com
Applied Nutrition plc
via Alma
Thomas Ryder, Chief Executive Officer
Steven Granite, Chief Operating Officer
Joe Pollard, Chief Financial Officer
Alma Strategic Communications
(Public Relations adviser to Applied Nutrition)
+44 (0) 203 405 0205
appliednutrition@almastrategic.com
Rebecca Sanders-Hewett, Sam Modlin, Joe Pederzolli, Sarah Peters
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation. The person responsible for arranging the release of this announcement on behalf of Applied Nutrition is Joe Pollard, Chief Financial Officer.
Forward-looking statements
Cautionary Statement – Certain statements included or incorporated by reference within this announcement may constitute “forward-looking statements” in respect of the Group’s operations, performance, prospects and/or financial condition. Forward-looking statements are sometimes, but not always, identified by their use of a date in the future or such words and words of similar meaning as “anticipates”, “aims”, “due”, “could”, “may”, “will”, “should”, “expects”, “believes”, “intends”, “plans”, “potential”, “targets”, “goal” or “estimates”. By their nature, forward looking statements involve a number of risks, uncertainties and assumptions and actual results or events may differ materially from those expressed or implied by those statements. Accordingly, no assurance can be given that any particular expectation will be met, and reliance should not be placed on any forward-looking statement. Additionally, forward-looking statements regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. No responsibility or obligation is accepted to update or revise any forward-looking statement resulting from new information, future events or otherwise. Nothing in this announcement should be construed as a profit forecast. This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any shares or other securities in the Company, nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment or investment decisions relating thereto, nor does it constitute a recommendation regarding the shares or other securities of the Company. Past performance cannot be relied upon as a guide to future performance and persons needing advice should consult an independent financial adviser. Statements in this announcement reflect the knowledge and information available at the time of its preparation. Liability arising from anything in this announcement shall be governed by English law. Nothing in this announcement shall exclude any liability under applicable laws that cannot be excluded in accordance with such laws.
Notes to editors
Applied Nutrition plc (LSE: APN) is a leading sports nutrition, health and wellness brand, which formulates and creates nutrition products with a stated aim of being the world’s most trusted and innovative brand in the market.
Headquartered in the UK, the Group sells products in over 85 countries worldwide and has a diverse product range, targeting elite athletes, gym goers and health-conscious consumers. Applied Nutrition has developed and launched four ranges under the umbrella of the Applied Nutrition brand – Applied Nutrition, ABE, BodyFuel, and Endurance. Across the four ranges, the Group sells over 120 different products.
The Group’s success has been built on an exceptional product range developed in-house in Knowsley, Liverpool, by a team of experts, allowing products to be developed efficiently delivering new innovation to the market, keeping existing products up to date, and introducing products aligned with latest trends.
The Group largely operates a global business-to-business (B2B) model, which has facilitated a low risk, highly cost-effective go-to-market strategy and has enabled strong, profitable growth in the UK, Europe and other international geographies. The business model and strategy has enabled the Group to become a fast-growing, highly profitable and cash generative global supplier in the sports nutrition, health and wellness market.
For further information, please visit www.appliednutritionplc.com
